自新冠病毒在欧洲爆发后，小伙伴就纷纷想着怎么从国内寄来像莲花清瘟之类的药品。据说，大使馆分发的健康包里也有这款药物。
5月6日，瑞典媒体称：这款号称可以治疗covid-19的中草药，瑞典当局对其进行了检测，在药品里仅发现了薄荷醇。
瑞典媒体称，据中国媒体报道，这种草药被称为“莲花清瘟”，可以抑制covid-19，治愈由病毒引起的炎症，甚至可以修复由疾病引起的细胞损伤。
“我们在3月和4月检获了该产品，该产品正在向新冠患者销售。”海关总署专家乔纳斯·卡尔森（Jonas Karlsson）说，我们以前从未见过它。
根据海关总署的文件，海关实验室对该药进行了分析，结果表明该药为“仅薄荷醇”。
瑞典药品管理局也指出，目前欧洲有大量的当前产品在流通。
瑞典药品管理局和海关署将这种产品描述为未经许可不得从申根区以外的国家运输的药物，因此将其停留在了边境。
丹·拉罕马尔（Dan Larhammar）是分子细胞生物学教授，他说“莲花清瘟”包含约13种草药，“成分只是薄荷醇”。
瑞典药品管理局也提出“警告”：“我们还没有任何研究表明该药有效，绝对不是我们推荐的东西。”
来源：https://www.wenxuecity.com/news/2020/05/08/9437282.html
================================================
Chinese netizens mock Swedish Customs' 'testing' of Chinese medicine, say it deserves a Nobel Prize
Swedish Customs' accusation and embargo of Chinese medicine Lianhua Qingwen as ineffective just by testing capsule components showed the European country's bias toward Chinese herbal remedy, Chinese experts said on Friday, noting that the baseless prejudice will also impede its ability in handling the COVID-19 in the future.
The comments came after Swedish Customs reportedly held a batch of Lianhua Qingwen capsules, and after testing the capsules, only found menthol. "It does not work," local media reported.
The Swedish Medicines Agency also warned that "It's definitely not something we recommend," despite it having been widely spread across Europe, reports said.
Menthol is just one of the 13 components of the medicine, Shijiazhuang Yiling Pharmaceutical Co., the company that produced the capsule, told the Global Times in a statement on Friday, adding that the capsules are not registered in Sweden nor authorized for export in the country.
"The Swedish Customs' conduct is biased and unreasonable. The effect of Lianhua Qingwen cannot be determined by merely checking its components. So how can they arbitrarily restrict its entry?" Yang Zhanqiu, deputy director of the pathogen biology department at Wuhan University, told the Global Times on Friday.
Customs checks the legality of imported products, and the Swedish Customs restrictions on Lianhua Qingwen lack evidence - the effect of medicine, Yang said.
The reported move has also sparked discussions on Chinese social media.
"The restrictions reflect Sweden's discrimination against Chinese people living in the European country. Apart from Chinese in Sweden, who else will take the medicine? Has the Swedish government proven that Lianhua Qingwen is ineffective?" a netizen named Bolin said on China's twitter-like Weibo platform on Friday.
"How can Swedish Customs just deny the medical effects by just gauging its ingredients? If medical science works like this, Swedish Customs should be granted a Nobel Prize for Medicine!" a netizen surnamed Fei said.
"If there is only menthol just as the Customs claimed - the medicine is not poison-- why not allow the import? I think there are some hidden reasons that the country tries to impose the restrictions," said another netizen named Jay.
The medicine has been proven effective for treating COVID-19 through experiments, China's top respiratory expert Zhong Nanshan said previously. Lianhua Qingwen can inhibit the virus and repair cell injuries and inflammation caused by the virus. The medicine can be more effective for COVID-19 patients showing mild symptoms.
Patients' symptoms improved earlier than those who did not take the capsule and CT scan results also showed that patients recover faster after treatment. In addition, the capsule can shorten fever time, Zhong said.
Lianhua Qingwen products have been registered in eight countries, including Brazil, Thailand, Ecuador, and Singapore, the firm said, noting that orders for the medicine have also increased significantly.
The company has started registration application work for the medicine in many countries such in the Middle East, Africa, and Latin America, and the Phase II clinical work for FDA registration in the US is also advancing as planned, the firm said.
Sweden's rejection also comes with its unusually hands-off approach in the face of the crisis. It refused to impose a lockdown in the country, a dangerous experiment that puts lives at risk.
More than 24,600 infected cases have been found in the country, with a death toll of over 3,000 as of Friday. The country has a population of about 10 million.
Due to different social and culture habits, it's understandable that some cannot accept the TCM treatment immediately, even if it has proven effective in China's fight against the virus. But as the pandemic spreads and greatly hurts people's health, every treatment is worth a try, instead of just leaving it behind due to prejudice, experts said.
Basic and clinical studies have confirmed that Lianhua Qingwen not only has a killing effect on influenza viruses such as H1N1, H3N2, Avian Influenza H7N9, and Influenza B viruses, but also on other infectious pathogens such as the parainfluenza virus and SARS, the firm said.
In China, the capsule was used by 70 million people as of mid-March.
来源：https://www.globaltimes.cn/content/1187794.shtml
